- Currently, there is no cure for Alzheimer's disease.
- Researchers are continually testing the effectiveness of various drug therapies that will control symptoms; slow, reduce and/or reverse mental and behavioral symptoms; and prevent or halt the disease.
The U.S. Food and Drug Administration (FDA) has approved several medications for the treatment of Alzheimer’s disease: donepezil hydrochloride (Aricept), approved for all stages of Alzheimer's disease; rivastigmine (Exelon), approved in pill and patch form for mild to moderate Alzheimer's disease; galantamine hydrobromide (Razadyne), approved for mild to moderate Alzheimer's disease; and memantine HCI (Namenda) for the treatment of moderate to severe Alzheimer's disease.
Some of these medications can be used alone or in combination, and can provide some relief of symptoms and may slow the decline in mental function to some extent.
The FDA has approved memantine HCI (Namenda) for the treatment of moderate to severe Alzheimer's disease, which may help slow the worsening of symptoms.
- Currently, research supports behavioral management interventions for individuals with dementia, as well as education, counseling and other support services for caregivers.
- The National Institute on Aging, in concert with the FDA, tracks private- and government-sponsored clinical trials; contact the Alzheimer's Disease Education and Referral Center (www.alzheimers.org/trials or 800-438-4380). AFA also lists clinical trials; click here.
For more information, connect with the Alzheimer’s Foundation of America’s licensed social workers. Click here or call 866.AFA.8484. Real People. Real Care.
Alzheimer's Foundation of America 866.AFA.8484